EUVIMEDEUVIMED entdecken
Übersichtsarbeit

HBx protein as a therapeutic target for functional cure of hepatitis B virus infection

Vijay Kumar

Virology · 2025-03 · 604 · 110438

DOI: 10.1016/j.virol.2025.110438 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Virology, 2025-03. Verfasst von Vijay Kumar. Beteiligte Einrichtung: Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Electronic address: vkumar@ilbs.in. Hauptthemen laut MEDLINE: Hepatitis B virus, Antiviral Agents, Trans-Activators, Hepatitis B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) is a major cause of acute and chronic liver disease and represents a major public health problem worldwide. Current antiviral therapies with nucleos(t)ide analogues can effectively suppressing viremia but are not curative, and have little or no impact upon the HBV cccDNA minichromosome or the portions of integrated HBV DNA. Several alternative therapeutic strategies targeted at viral components and life cycle are under intense investigation. This article highlights the reasons for considering HBx as a therapeutic target as this may allow targeting of both virus and disease. Recent studies focused at HBx have led to the identification of several new pharmacological agents and development of some novel therapeutic approaches that now deserve to be taken to the next level for better management of hepatitis B. Besides, new therapies could be combined with other established therapies, to provide a functional cure from hepatitis B infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusAntiviral AgentsTrans-ActivatorsHepatitis BHumansViral Regulatory and Accessory ProteinsAnimalsVirus Replication

Substanzen

Antiviral Agentshepatitis B virus X proteinViral Regulatory and Accessory ProteinsTrans-Activators

Autor:innen und Institutionen

  • Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Electronic address: vkumar@ilbs.in.

Förderung

  • India Ministry of Science & Technology Department of Science and Technology

Zitieren

APA

Kumar, V. (2025). HBx protein as a therapeutic target for functional cure of hepatitis B virus infection. Virology, 604, 110438. https://doi.org/10.1016/j.virol.2025.110438

Vancouver

Kumar V. HBx protein as a therapeutic target for functional cure of hepatitis B virus infection. Virology. 2025;604:110438. doi:10.1016/j.virol.2025.110438

BibTeX
@article{Kumar2025,
  author = {Kumar, Vijay},
  title = {HBx protein as a therapeutic target for functional cure of hepatitis B virus infection},
  journal = {Virology},
  year = {2025},
  volume = {604},
  pages = {110438},
  doi = {10.1016/j.virol.2025.110438}
}
Kostenlos starten →